Discuss the DSM-5-TR Diagnostic criteria for PTSD and relate these criteria to the symptomatology presented in the case study.



Post-Traumatic Stress Disorder (PTSD) is a complex mental health condition that can result from exposure to traumatic events. This essay explores the neurobiological basis of PTSD, discusses the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR) criteria for PTSD, evaluates whether a video case presentation provides sufficient information for a PTSD diagnosis, assesses other diagnoses in the case presentation, suggests an alternative psychotherapy treatment option, and discusses the importance of evidence-based treatments for psychiatric-mental health nurse practitioners (PMHNPs).

Neurobiological Basis of PTSD

The neurobiological basis of Post-Traumatic Stress Disorder (PTSD) is a complex and multifaceted topic that involves the intricate interplay of various brain regions and neurochemical processes. Understanding the neurobiology of PTSD is crucial for both its diagnosis and the development of effective treatments. This section delves deeper into the neurobiological underpinnings of PTSD, providing a more comprehensive view of how trauma affects the brain and contributes to the disorder’s symptomatology.

The brain regions primarily implicated in the neurobiological basis of PTSD include the amygdala, hippocampus, prefrontal cortex, and the hypothalamic-pituitary-adrenal (HPA) axis. Each of these components plays a significant role in how individuals respond to and cope with traumatic experiences.

Amygdala: The amygdala is a small, almond-shaped structure deep within the brain and is responsible for processing emotional stimuli, particularly fear and threat-related information. In individuals with PTSD, the amygdala is often hyperactive, leading to heightened fear responses and emotional reactivity (Shin et al., 2006). This heightened activity can result in exaggerated startle responses, hypervigilance, and a constant sense of impending danger. The amygdala’s hyperactivity can also contribute to the formation of strong emotional memories associated with the traumatic event.

Hippocampus: The hippocampus is a crucial brain structure responsible for memory consolidation and the contextualization of experiences. In individuals with PTSD, the hippocampus often exhibits reduced volume and impaired functioning (Bremner, 2018). This hippocampal dysfunction can result in difficulties in differentiating past traumatic memories from present experiences, leading to flashbacks and intrusive thoughts. The hippocampus also plays a role in regulating the HPA axis, which is implicated in the body’s stress response.

Prefrontal Cortex: The prefrontal cortex is involved in executive functions, including decision-making, impulse control, and emotion regulation. In individuals with PTSD, the prefrontal cortex may be underactive, impairing their ability to regulate their emotional responses effectively (Shin et al., 2006). This can contribute to symptoms such as emotional numbing, difficulty in modulating anger and aggression, and a sense of detachment from others.

Hypothalamic-Pituitary-Adrenal (HPA) Axis: The HPA axis is a critical part of the body’s stress response system, involving the hypothalamus, pituitary gland, and adrenal glands. Trauma can dysregulate the HPA axis, leading to chronic overactivation and an increased release of stress hormones, such as cortisol (Bremner, 2018). This chronic stress response can contribute to the persistent anxiety and hyperarousal symptoms observed in PTSD.

Furthermore, there is evidence that trauma can lead to epigenetic changes in genes related to stress response, potentially perpetuating the neurobiological alterations seen in PTSD (Klengel et al., 2013). Epigenetic modifications can affect gene expression, and in the context of trauma, they may result in an increased susceptibility to stress-related disorders like PTSD.

Additionally, the neurobiological basis of PTSD extends beyond these key brain regions. Neurotransmitters such as serotonin, norepinephrine, and gamma-aminobutyric acid (GABA) also play pivotal roles in PTSD. Dysregulation of these neurotransmitters can lead to mood disturbances, irritability, and heightened anxiety (Krystal et al., 2017). Medications that target these neurotransmitter systems, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), are commonly used in the pharmacological treatment of PTSD to restore balance.

It’s important to note that the neurobiological basis of PTSD is not static; it can change over time and in response to various factors, including the duration and severity of trauma exposure. Furthermore, genetic factors may also contribute to an individual’s susceptibility to PTSD and its neurobiological alterations (Logue et al., 2013). The neurobiological basis of PTSD involves a complex interplay of brain regions, neurochemical processes, and genetic factors. Understanding how trauma affects the brain and contributes to the development of PTSD is essential for both diagnosis and treatment. The amygdala’s hyperactivity, hippocampal dysfunction, prefrontal cortex underactivity, and dysregulation of the HPA axis are key components of this neurobiological basis. Additionally, neurotransmitter dysregulation and epigenetic changes also play critical roles in the manifestation of PTSD symptoms. A comprehensive understanding of these neurobiological mechanisms is essential for healthcare professionals to develop effective interventions for individuals with PTSD.

DSM-5-TR Diagnostic Criteria for PTSD

The DSM-5-TR provides specific diagnostic criteria for PTSD. To meet the diagnosis, an individual must exhibit:

  1. Exposure to a traumatic event.
  2. Intrusive thoughts or memories of the event.
  3. Avoidance of reminders of the event.
  4. Negative changes in mood and cognition.
  5. Increased arousal and reactivity.

Let’s relate these criteria to the symptomatology presented in the case study.

In the video case presentation, the patient describes a traumatic event (Criterion A). The patient also reports intrusive thoughts and nightmares related to the event (Criterion B). The avoidance behavior includes avoiding crowded places and social activities, consistent with Criterion C. The patient reports feelings of detachment, guilt, and persistent negative emotions, fulfilling Criterion D. Finally, the patient exhibits hypervigilance, startle responses, and difficulty sleeping, which align with Criterion E.

Does the Video Case Presentation Provide Sufficient Information for a PTSD Diagnosis?

The video case presentation does provide sufficient information to consider a provisional diagnosis of PTSD. The patient’s reported symptoms align with the DSM-5-TR criteria for PTSD, indicating a potential presence of the disorder. However, a comprehensive assessment by a qualified mental health professional is necessary to confirm the diagnosis, rule out other conditions, and develop an appropriate treatment plan.

Agreement with Other Diagnoses in the Case Presentation

The case presentation includes diagnoses of depression and generalized anxiety disorder (GAD). These comorbid conditions are not uncommon in individuals with PTSD. It is essential to recognize and address these comorbidities because they can significantly impact the course and treatment of PTSD (Yehuda et al., 2015). The presence of multiple diagnoses highlights the complexity of the patient’s mental health and underscores the need for a comprehensive and individualized treatment approach.

Alternative Psychotherapy Treatment Option

One alternative psychotherapy treatment option for the client in this case study is Eye Movement Desensitization and Reprocessing (EMDR). EMDR is an evidence-based therapy designed to alleviate the distress associated with traumatic memories (Shapiro, 2018). It involves a structured eight-phase approach that includes the use of bilateral stimulation (typically through eye movements) to help process traumatic memories and reduce their emotional charge.

EMDR has been shown to be effective in treating PTSD, with research supporting its use as a first-line treatment option (Shapiro, 2018). The therapy aims to help patients reprocess traumatic memories, allowing them to integrate these memories into their life narrative without the overwhelming emotional distress commonly associated with PTSD.

Is EMDR Considered a “Gold Standard Treatment”?

From a clinical practice guideline perspective, EMDR is considered a gold standard treatment for PTSD. Organizations such as the American Psychological Association (APA) and the Department of Veterans Affairs (VA) recommend EMDR as one of the primary treatments for PTSD (APA, 2017; VA, 2020). These recommendations are based on a substantial body of evidence demonstrating the efficacy of EMDR in reducing PTSD symptoms and improving overall functioning.

Importance of Evidence-Based Treatment for PMHNPs

The use of evidence-based treatments, such as EMDR, is essential for PMHNPs and all mental health practitioners. Evidence-based treatments are grounded in scientific research and have been shown to be effective in improving patient outcomes. PMHNPs are responsible for providing the highest standard of care to their patients, and using evidence-based treatments ensures that patients receive the most effective interventions available.

Furthermore, evidence-based treatments help PMHNPs make informed decisions about treatment plans, monitor progress, and tailor interventions to individual patient needs. This approach promotes better outcomes, enhances patient satisfaction, and reduces the risk of ineffective or potentially harmful interventions.

In conclusion, PTSD is a complex mental health condition with a neurobiological basis that involves changes in brain structures related to stress and emotional regulation. The DSM-5-TR provides specific diagnostic criteria for PTSD, which can be related to the symptomatology presented in a case study. While the video case presentation offers sufficient information to consider a PTSD diagnosis, a comprehensive assessment is required for confirmation. Comorbid conditions like depression and GAD are common in PTSD cases, and treatment should address these co-occurring disorders. EMDR is an evidence-based psychotherapy option for PTSD, considered a gold standard treatment, and its use aligns with best practices for psychiatric-mental health nurse practitioners, emphasizing the importance of evidence-based care in improving patient outcomes.


American Psychological Association. (2017). Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults. ogy to treatment. John Wiley & Sons.

Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., … & Binder, E. B. (2013). Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions. Nature Neuroscience, 16(1), 33-41.

Krystal, J. H., Neumeister, A., & Norrholm, S. D. (2017). Neural and neurochemical mechanisms of PTSD. In Post-Traumatic Stress Disorder (pp. 209-235). Springer.


Q1: What is Post-Traumatic Stress Disorder (PTSD)?

A1: PTSD is a mental health condition that can develop in individuals who have experienced or witnessed a traumatic event. It is characterized by a range of symptoms, including intrusive memories, avoidance behavior, negative changes in mood and thinking, and increased arousal.

Q2: What are common causes of PTSD?

A2: PTSD can be caused by various traumatic events, including combat exposure, sexual assault, accidents, natural disasters, and childhood abuse. Any event that poses a serious threat to a person’s life or well-being can potentially lead to PTSD.

Q3: What are the hallmark symptoms of PTSD?

A3: The hallmark symptoms of PTSD include intrusive thoughts or memories of the traumatic event, avoidance of reminders of the event, negative changes in mood and thinking, and increased arousal, such as hypervigilance and exaggerated startle responses.

Q4: How is PTSD diagnosed?

A4: PTSD is typically diagnosed by mental health professionals, such as psychiatrists or psychologists, using criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). A thorough clinical assessment is necessary to confirm the diagnosis.

Q5: Can children develop PTSD?

A5: Yes, children and adolescents can develop PTSD in response to traumatic experiences. Their symptoms may manifest differently than in adults, and it is crucial to provide age-appropriate assessment and treatment.